Impact of the Spread of COVID-19 on Sales and Distribution Activities and Business Performance
First written in FY2021-Q1. 8 of 10 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026ReframedAnnual report
「The company and the Group are taking steps to prevent the spread of various infectious diseases, prioritizing the health and safety of customers, employees and others.」
The scope has been generalized from the previous wording focused on COVID-19 to "various infectious diseases." - FY2023RestatedAnnual report
「The company and the Group are taking steps to prevent infection, prioritizing the health and safety of customers, employees and others, in order to prevent the spread of COVID-19. However, if the spread of COVID-19 disrupts the Group's sales, distribution or procurement activities, or causes further personal harm, the financial condition and business performance of the company and the Group may be affected by temporary store closures, expenditures on countermeasures and other factors.」
The company continues to identify as risks to business performance the disruption of sales, distribution and procurement activities, personal harm, temporary store closures and countermeasure costs resulting from infection. - FY2023-Q3RestatedAnnual report
「There have been no material changes to the assumptions described in the securities report for the previous consolidated fiscal year under (Additional Information) (Accounting Estimates Related to the Impact of the Spread of COVID-19), including assumptions about how COVID-19 will spread in the future and when it will subside.」
The company is reconfirming that there have been no material changes to its previous assumptions regarding how COVID-19 will spread and when it will subside. - FY2023-Q2RestatedAnnual report
「Accounting estimates related to the impact of the spread of COVID-19 There have been no material changes to the assumptions described in the securities report for the previous consolidated fiscal year under (Additional Information) (Accounting Estimates Related to the Impact of the Spread of COVID-19), including assumptions about how COVID-19 will spread in the future and when it will subside.」
The company states that there have been no material changes to its previous assumptions regarding the spread of infection and the timing of its subsidence. - FY2022RestatedAnnual report
「If the spread of COVID-19 disrupts the Group's sales, distribution or procurement activities, or causes further personal harm, the financial condition and business performance of the company and the Group may be affected by temporary store closures, expenditures on countermeasures and other factors.」
The company continues to identify as risks to business performance the disruption of sales, distribution and procurement activities, personal harm, temporary store closures and countermeasure costs resulting from infection. - FY2022-Q2RestatedAnnual report
「Close attention remains necessary to the risk that infection trends could cause the domestic and overseas economies to undershoot expectations. Uncertainty about the outlook continues, including the impact of volatility in the financial and capital markets.」
The company continues to state the risks of an economic downturn resulting from infection trends, volatility in the financial and capital markets, and continued uncertainty about the outlook. - FY2021RestatedAnnual report
「The company and the Group are taking steps to prevent infection, prioritizing the health and safety of customers, employees and others, in order to prevent the spread of COVID-19. However, if the spread of COVID-19 disrupts the Group's sales, distribution or procurement activities, or causes further personal harm, the financial condition and business performance of the company and the Group may be affected by temporary store closures, expenditures on countermeasures and other factors.」
The company continues to identify as risks to business performance the disruption of sales, distribution and procurement activities, personal harm, temporary store closures and countermeasure costs resulting from the spread of infection. - FY2021-Q3RestatedAnnual report
「To prevent the spread of COVID-19, the company is taking steps to prevent infection, prioritizing the health and safety of customers, employees and others. If the spread of COVID-19 disrupts the Group's sales, distribution or procurement activities, or causes further personal harm, the Group's financial condition and business performance may be affected by temporary store closures, expenditures on countermeasures and other factors.」
The company is reiterating the same risks to business performance from COVID-19, including disruptions to sales, distribution and procurement activities, personal harm, temporary store closures and countermeasure costs. - FY2021-Q2RestatedAnnual report
「To prevent the spread of COVID-19, the company is taking steps to prevent infection, prioritizing the health and safety of customers, employees and others. If the spread of COVID-19 disrupts the Group's sales, distribution or procurement activities, or causes further personal harm, the Group's financial condition and business performance may be affected by temporary store closures, expenditures on countermeasures and other factors.」
The company is reiterating the same risks to business performance from the spread of COVID-19, including disruptions to sales, distribution and procurement activities, personal harm, temporary store closures and countermeasure costs. - FY2021-Q1First statedAnnual report
「To prevent the spread of COVID-19, the company is taking steps to prevent infection, prioritizing the health and safety of customers, employees and others. If the spread of COVID-19 disrupts the Group's sales, distribution or procurement activities, or causes further personal harm, the Group's financial condition and business performance may be affected by temporary store closures, expenditures on countermeasures and other factors.」
The company has added as risks that the spread of COVID-19 may disrupt sales, distribution and procurement activities, cause personal harm, temporary store closures and countermeasure costs, and affect financial condition and business performance.